Keywords
Adenomyosis
Sex hormones
Menstrual volume
Submitted : 2025-05-01
Accepted : 2025-05-16
Published : 2025-05-31
Abstract
Objective: To explore the efficacy of the Mirena intrauterine device (IUD) in the treatment of patients with adenomyosis. Methods: Forty patients with adenomyosis treated in our hospital from January 2021 to December 2024 were randomly divided into an observation group and a control group, with 20 cases in each group. The observation group received Mirena IUD treatment, while the control group received drug treatment. The treatment indicators were compared between the two groups. Results: The total effective rate in the observation group was higher than that in the control group (P < 0.05). After treatment, the levels of sex hormone indicators in the observation group were better than those in the control group (P < 0.05). Compared with the control group, the observation group had significant improvements in menstrual pain score, menstrual volume score, uterine volume, and endometrial thickness (P < 0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P < 0.05). Conclusion: The treatment of adenomyosis patients with Mirena IUD is significantly effective, which can effectively improve menstrual volume and reduce the degree of menstrual pain. With fewer adverse reactions, the treatment is safer and feasible for promotion.
References
Zhang Q, Zhang Y, Xu F, 2021, Effects of Mirena Combined with Leuprolide on Endometrial Indicators, Uterine Recovery, and Side Effects in Patients with Adenomyosis. Pharmaceutical Biotechnology, 28(3): 280–283.
He Y, Wang X, 2024, Analysis of the Effect of Mirena Combined with Low-Dose Dydrogesterone Tablets in the Treatment of Adenomyosis. Chinese Journal of Obstetrics and Gynecology, 25(3): 271–273.
Guo M, Deng Z, Xu H, 2020, Clinical Study of Mirena Combined with Gonadotropin-Releasing Hormone Agonist in the Treatment of Adenomyosis. Journal of Guangxi Medical University, 37(3): 4.
Yang X, Li J, 2022, Clinical Efficacy Analysis of Mirena Ring in the Treatment of Adenomyosis. Chinese Maternal and Child Health Care, 37(2): 4.
Tian Y, Ran L, Gu X, et al., 2020, Evaluation of the Clinical Effect of Mirena Combined with Leuprolide in the Treatment of Adenomyosis with Ovarian Endometriotic Cysts. Modern Digestion & Intervention, 2020(S01): 0294–0294.
Chu H, He Q, Yang L, 2023, Effects of Mirena Combined with GnRH-a on Postoperative Uterine Volume, Serum HE4 Level, and Menstrual Blood Volume in Patients with Adenomyosis. Chinese Journal of Family Planning, 31(1): 32–36.
Wang L, Fan A, 2023, Efficacy of Goserelin Acetate Combined with Mirena in the Treatment of Adenomyosis and Its Effects on Endometrial Receptivity and Serum CA125, CA199, and HE4. Pharmaceutical Biotechnology, 30(5): 498–502.
Wang N, Yang S, Li X, et al., 2023, Clinical Observation on the Efficacy of Intrauterine Placement of Mirena IUD in the Treatment of Adenomyosis. Database of Chinese Scientific and Technological Periodicals (Abstract Version) Medicine and Health, 2023(2): 64–66.
Yuan Y, Zhang Y, Guo Y, 2023, To Investigate the Effects of Levonorgestrel Intrauterine System on Endometrial Receptivity and Hemodynamics in Patients with Adenomyosis. Sichuan Journal of Physiological Sciences, 45(8): 1385–1387.
Lin Y, 2023, Application of Levonorgestrel Intrauterine System Combined with Desogestrel and Ethinylestradiol Tablets in the Drug Treatment of Adenomyosis. Northern Pharmacology, 20(11): 104–106.
Li R, Zhen W, Guo P, et al., 2023, Clinical Observation on the Efficacy of Leuprolide Combined with Levonorgestrel Intrauterine Sustained-Release System (Mirena) in the Treatment of Adenomyosis. The 6th National Rehabilitation and Clinical Pharmacy Academic Exchange Conference, Xindu Central Hospital, Xingtai City, Hebei Province, 7.
Liu F, Zhang J, 2024, Effects of Leuprolide Acetate Combined with Mirena on Endometrial Receptivity and Serum CA125, CA199, and HE4 Levels in Patients with Adenomyosis. Aerospace Medicine, 2024(12): 1453–1455.
Li M, 2023, Effects of Mirena Combined with Leuprolide on Estrogen/Progesterone Levels and Endometrial Thickness in Patients with Adenomyosis. Special Health, 2023: 37–39.
You X, 2023, Effect of Goserelin Combined with Mirena in the Treatment of Adenomyosis and Its Influence on Endometrial Thickness and Sex Hormone Levels. Primary Medical Forum, 27(19): 85–87.
Shi C, Zhang J, 2024, Clinical Value Analysis of Mirena Combined with Gonadotropin-Releasing Hormone Agonist in the Treatment of Adenomyosis. Marriage and Child Health Care, 2024(19): 34–36.